Cite

HARVARD Citation

    Pagliarini, R. et al. (n.d.). Identification of STX-721, an EGFR exon 20 mutant inhibitor with superior selectivity and a potential best-in-class profile. European journal of cancer. pp. S29-S30. [Online]. 
  
Back to record